Phase I-II study of Plitidepsin and Dacarbazine as first-line therapy for advanced melanoma.
Authors
Plummer, RLorigan, Paul C
Brown, E
Zaucha, R
Moiseyenko, V
Demidov, L
Soriano, V
Chmielowska, E
Andrés, R
Kudryavtseva, G
Kahatt, C
Szyldergemajn, S
Extremera, S
de Miguel, B
Cullell-Young, M
Calvert, H
Affiliation
Northern Centre for Cancer Care, Freeman Hospital, Newcastle upon Tyne, NE7 7DN, UK.Issue Date
2013-09-17
Metadata
Show full item recordAbstract
This phase I-II trial compared plitidepsin 1-h infusion alone or combined with dacarbazine (DTIC) 1-h infusion as front-line therapy for advanced melanoma.Citation
Phase I-II study of Plitidepsin and Dacarbazine as first-line therapy for advanced melanoma. 2013, 109 (6):1451-9 Br J CancerJournal
British Journal of CancerDOI
10.1038/bjc.2013.477PubMed ID
23989947Type
ArticleLanguage
enISSN
1532-1827ae974a485f413a2113503eed53cd6c53
10.1038/bjc.2013.477
Scopus Count
Collections
Related articles
- Dacarbazine and interferon alpha with or without interleukin 2 in metastatic melanoma: a randomized phase III multicentre trial of the Dermatologic Cooperative Oncology Group (DeCOG).
- Authors: Hauschild A, Garbe C, Stolz W, Ellwanger U, Seiter S, Dummer R, Ugurel S, Sebastian G, Nashan D, Linse R, Achtelik W, Mohr P, Kaufmann R, Fey M, Ulrich J, Tilgen W
- Issue date: 2001 Apr 20
- Phase II study of plitidepsin in pretreated patients with locally advanced or metastatic non-small cell lung cancer.
- Authors: Peschel C, Hartmann JT, Schmittel A, Bokemeyer C, Schneller F, Keilholz U, Buchheidt D, Millan S, Izquierdo MA, Hofheinz RD
- Issue date: 2008 Jun
- Phase II study of biweekly plitidepsin as second-line therapy in patients with advanced malignant melanoma.
- Authors: Eisen T, Thomas J, Miller WH Jr, Gore M, Wolter P, Kavan P, Martín JA, Lardelli P
- Issue date: 2009 Jun
- Phase II clinical and pharmacokinetic study of plitidepsin 3-hour infusion every two weeks alone or with dexamethasone in relapsed and refractory multiple myeloma.
- Authors: Mateos MV, Cibeira MT, Richardson PG, Prosper F, Oriol A, de la Rubia J, Lahuerta JJ, García-Sanz R, Extremera S, Szyldergemajn S, Corrado C, Singer H, Mitsiades CS, Anderson KC, Bladé J, San Miguel J
- Issue date: 2010 Jun 15
- Sequential administration of varying doses of dacarbazine and fotemustine in advanced malignant melanoma.
- Authors: Lee SM, Margison GP, Woodcock AA, Thatcher N
- Issue date: 1993 Jun